The Role of the Federal Trade Commission in Regulating Over-the-Counter Drug Advertising

Abstract

Mr. Donegan's presentation touches upon some of the legislative and administrative problems facing the FTC in reviewing unfair practices in drug advertising. The FTC's primary concern is with the truthfulness of advertising practices and is now requiring substantiation of drug claims. Mr. Donegan sees a move in the direction of reviewing the possible relations between drug advertising and drug abuse. He actively encourages empirical research to substantiate this charge.